LeMaitre Vascular, Inc. (LMAT) — 分析摘要
LeMaitre Vascular, Inc.(LMAT)的市值为2.29十亿美元,最近一年的营收同比增长了+13.5%。净利润率为23.1%。当前市盈率为36.7倍。
核心要点
- 营收同比变化+13.5%
- 净利润率23.1%
- 市盈率36.7倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,LMAT的营收增长为+13.5%,市盈率为36.7倍。
LeMaitre Vascular, Inc. (LMAT)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
655
总部
BURLINGTON, MA
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$1.00
股息收益率
1.02%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。